Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases

Abstract Background Chondroblastoma is classified as a benign bone tumor. However, postoperative local recurrence remains a concern. We analyzed the factors contributing to chondroblastoma local recurrence and the clinical challenges associated with treating these patients. Methods This retrospectiv...

Full description

Saved in:
Bibliographic Details
Main Authors: Toru Hirozane, Tetsuya Sekita, Eisuke Kobayashi, Tomoaki Mori, Naofumi Asano, Toru Udaka, Takashi Tajima, Rumi Nakagawa, Kazutaka Kikuta, Akira Yoshiyama, Hideo Morioka, Itsuo Watanabe, Ukei Anazawa, Michiro Susa, Keisuke Horiuchi, Yoshihisa Suzuki, Takeshi Morii, Robert Nakayama
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Surgery
Subjects:
Online Access:https://doi.org/10.1186/s12893-025-02782-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586064442687488
author Toru Hirozane
Tetsuya Sekita
Eisuke Kobayashi
Tomoaki Mori
Naofumi Asano
Toru Udaka
Takashi Tajima
Rumi Nakagawa
Kazutaka Kikuta
Akira Yoshiyama
Hideo Morioka
Itsuo Watanabe
Ukei Anazawa
Michiro Susa
Keisuke Horiuchi
Yoshihisa Suzuki
Takeshi Morii
Robert Nakayama
author_facet Toru Hirozane
Tetsuya Sekita
Eisuke Kobayashi
Tomoaki Mori
Naofumi Asano
Toru Udaka
Takashi Tajima
Rumi Nakagawa
Kazutaka Kikuta
Akira Yoshiyama
Hideo Morioka
Itsuo Watanabe
Ukei Anazawa
Michiro Susa
Keisuke Horiuchi
Yoshihisa Suzuki
Takeshi Morii
Robert Nakayama
author_sort Toru Hirozane
collection DOAJ
description Abstract Background Chondroblastoma is classified as a benign bone tumor. However, postoperative local recurrence remains a concern. We analyzed the factors contributing to chondroblastoma local recurrence and the clinical challenges associated with treating these patients. Methods This retrospective study examined 59 patients followed up at our hospitals for ≥ 1 year after surgery during 1990–2020. The most common lesion site was the epiphyses of long bones (42 cases, 71%), including the femur, tibia, and humerus. Curettage was performed in 57 cases; 2 cases with an iliac lesion underwent resection. The median postoperative follow-up period was 47 months. Clinical features of chondroblastoma were retrospectively investigated, and local recurrence and postoperative functional outcomes were assessed. Results Local recurrence occurred in 9% (5/57) of patients after curettage but not in the resected cases. The median time to local recurrence was 14 months. The local recurrence-free survival (LRFS) rate for all patients was 92.7% at 2 years and 88.3% at 5 years. All patients with local recurrence were aged < 17 years at the time of surgery. Local recurrence was observed in the proximal humerus in two cases and the calcaneus, acetabulum, and distal femur in one case each. None of the adjuvant procedures (high-speed burr, ablation, bone replacement materials, and preoperative denosumab) helped reduce local recurrence risk (P > 0.05). Trends toward fewer local recurrences were observed in the group treated using the high-speed burr and in the group not treated using bone replacement materials. Among the groups treated with bone replacement materials, artificial bone achieved the best LRFS rate, followed by allograft and autograft. At the final follow-up, the mean Musculoskeletal Tumor Society score was 29.8 (range: 25–30), indicating excellent postoperative functional outcomes. Joint degeneration was observed in five patients. Patients with local recurrence had a high degree of disability and joint deformity (P < 0.05). Two patients received preoperative denosumab and neither experienced local recurrence nor functional impairments. Conclusions Good oncological and functional outcomes were achieved. Age < 17 years was associated with a high risk of local recurrence after curettage (P = 0.0198). Patients with local recurrence exhibited poorer functional outcomes. High-speed burr may help reduce the recurrence risk. If bone grafts are necessary, materials with low biocompatibility, including artificial bone, may be optimal. Managing patients with chondroblastoma should encompass curative and functional aspects.
format Article
id doaj-art-74ec65e8c1344a6a91d1942370a20fbc
institution Kabale University
issn 1471-2482
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Surgery
spelling doaj-art-74ec65e8c1344a6a91d1942370a20fbc2025-01-26T12:12:42ZengBMCBMC Surgery1471-24822025-01-0125111410.1186/s12893-025-02782-3Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 casesToru Hirozane0Tetsuya Sekita1Eisuke Kobayashi2Tomoaki Mori3Naofumi Asano4Toru Udaka5Takashi Tajima6Rumi Nakagawa7Kazutaka Kikuta8Akira Yoshiyama9Hideo Morioka10Itsuo Watanabe11Ukei Anazawa12Michiro Susa13Keisuke Horiuchi14Yoshihisa Suzuki15Takeshi Morii16Robert Nakayama17Department of Orthopaedic Surgery, Keio University School of MedicineDepartment of Musculoskeletal Oncology, National Cancer Center HospitalDepartment of Musculoskeletal Oncology, National Cancer Center HospitalDepartment of Orthopaedic Surgery, Keio University School of MedicineDepartment of Orthopaedic Surgery, Keio University School of MedicineDepartment of Orthopaedic Surgery, Faculty of Medicine, Kyorin UniversityDepartment of Orthopaedic Surgery, Faculty of Medicine, Kyorin UniversityDivision of Musculoskeletal Oncology and Orthopaedic Surgery, Tochigi Cancer CenterDivision of Musculoskeletal Oncology and Orthopaedic Surgery, Tochigi Cancer CenterDepartment of Orthopaedic Surgery, National Hospital Organization Tokyo Medical CenterDepartment of Orthopaedic Surgery, National Hospital Organization Tokyo Medical CenterDepartment of Orthopaedic Surgery, Tokyo Dental College Ichikawa General HospitalDepartment of Orthopaedic Surgery, Tokyo Dental College Ichikawa General HospitalDepartment of Orthopaedic Surgery, National Defense Medical CollegeDepartment of Orthopaedic Surgery, National Defense Medical CollegeDepartment of Orthopaedic Surgery, Tachikawa HospitalDepartment of Orthopaedic Surgery, Faculty of Medicine, Kyorin UniversityDepartment of Orthopaedic Surgery, Keio University School of MedicineAbstract Background Chondroblastoma is classified as a benign bone tumor. However, postoperative local recurrence remains a concern. We analyzed the factors contributing to chondroblastoma local recurrence and the clinical challenges associated with treating these patients. Methods This retrospective study examined 59 patients followed up at our hospitals for ≥ 1 year after surgery during 1990–2020. The most common lesion site was the epiphyses of long bones (42 cases, 71%), including the femur, tibia, and humerus. Curettage was performed in 57 cases; 2 cases with an iliac lesion underwent resection. The median postoperative follow-up period was 47 months. Clinical features of chondroblastoma were retrospectively investigated, and local recurrence and postoperative functional outcomes were assessed. Results Local recurrence occurred in 9% (5/57) of patients after curettage but not in the resected cases. The median time to local recurrence was 14 months. The local recurrence-free survival (LRFS) rate for all patients was 92.7% at 2 years and 88.3% at 5 years. All patients with local recurrence were aged < 17 years at the time of surgery. Local recurrence was observed in the proximal humerus in two cases and the calcaneus, acetabulum, and distal femur in one case each. None of the adjuvant procedures (high-speed burr, ablation, bone replacement materials, and preoperative denosumab) helped reduce local recurrence risk (P > 0.05). Trends toward fewer local recurrences were observed in the group treated using the high-speed burr and in the group not treated using bone replacement materials. Among the groups treated with bone replacement materials, artificial bone achieved the best LRFS rate, followed by allograft and autograft. At the final follow-up, the mean Musculoskeletal Tumor Society score was 29.8 (range: 25–30), indicating excellent postoperative functional outcomes. Joint degeneration was observed in five patients. Patients with local recurrence had a high degree of disability and joint deformity (P < 0.05). Two patients received preoperative denosumab and neither experienced local recurrence nor functional impairments. Conclusions Good oncological and functional outcomes were achieved. Age < 17 years was associated with a high risk of local recurrence after curettage (P = 0.0198). Patients with local recurrence exhibited poorer functional outcomes. High-speed burr may help reduce the recurrence risk. If bone grafts are necessary, materials with low biocompatibility, including artificial bone, may be optimal. Managing patients with chondroblastoma should encompass curative and functional aspects.https://doi.org/10.1186/s12893-025-02782-3ChondroblastomaBone neoplasmCurettageLocal recurrenceDenosumab
spellingShingle Toru Hirozane
Tetsuya Sekita
Eisuke Kobayashi
Tomoaki Mori
Naofumi Asano
Toru Udaka
Takashi Tajima
Rumi Nakagawa
Kazutaka Kikuta
Akira Yoshiyama
Hideo Morioka
Itsuo Watanabe
Ukei Anazawa
Michiro Susa
Keisuke Horiuchi
Yoshihisa Suzuki
Takeshi Morii
Robert Nakayama
Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases
BMC Surgery
Chondroblastoma
Bone neoplasm
Curettage
Local recurrence
Denosumab
title Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases
title_full Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases
title_fullStr Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases
title_full_unstemmed Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases
title_short Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases
title_sort clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures a retrospective study of 59 cases
topic Chondroblastoma
Bone neoplasm
Curettage
Local recurrence
Denosumab
url https://doi.org/10.1186/s12893-025-02782-3
work_keys_str_mv AT toruhirozane clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT tetsuyasekita clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT eisukekobayashi clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT tomoakimori clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT naofumiasano clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT toruudaka clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT takashitajima clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT ruminakagawa clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT kazutakakikuta clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT akirayoshiyama clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT hideomorioka clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT itsuowatanabe clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT ukeianazawa clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT michirosusa clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT keisukehoriuchi clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT yoshihisasuzuki clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT takeshimorii clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases
AT robertnakayama clinicalcharacteristicsandoutcomesofpatientswithchondroblastomaundergoingsurgerywithvariousadjuvantproceduresaretrospectivestudyof59cases